Showing results (171-180 of 548) with videos related to

Sort By:
Pageof 55
European Urology|July 14, 2015
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason ScoreJonathan I Epstein, Michael J Zelefsky, Daniel D Sjoberg, et al.
World Journal of Urology|May 14, 2015
Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamicsTarek P Ghoneim, Daniel D Sjoberg, William Lowrance, et al.
BJU International|April 11, 2018
Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapyEugene K Cha, John P Sfakianos, Ranjit Sukhu, et al.
International Urology and Nephrology|July 10, 2015
Predicting length of stay after robotic partial nephrectomyWassim M Bazzi, Daniel D Sjoberg, Angelica A C Grasso, et al.
Urologic Oncology|October 31, 2020
Optimizing MRI-targeted prostate biopsy: the diagnostic benefit of additional targeted biopsy coresChad R Tracy, Kevin J Flynn, Daniel D Sjoberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 22, 2010
Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screeningCaroline J Savage, Hans Lilja, Angel M Cronin, et al.
The Journal of Sexual Medicine|December 9, 2019
Updating the International Index of Erectile Function: Evaluation of a Large Clinical Data SetAndrew J Vickers, Amy L Tin, Karandeep Singh, et al.
JCO Oncology Practice|January 10, 2025
Development and Validation of a Simplified Financial Toxicity Screening Tool for Use in Clinical PracticeBridgette Thom, Amy L Tin, Fumiko Chino, et al.
Journal of the National Cancer Institute|February 26, 2011
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detectionAndrew J Vickers, Cathee Till, Catherine M Tangen, et al.
Pageof 55